Afreena Nasir

670 total citations
7 papers, 552 citations indexed

About

Afreena Nasir is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pharmacology. According to data from OpenAlex, Afreena Nasir has authored 7 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 1 paper in Surgery and 1 paper in Pharmacology. Recurrent topics in Afreena Nasir's work include Natural Antidiabetic Agents Studies (4 papers), Diet, Metabolism, and Disease (4 papers) and Andrographolide Research and Applications (1 paper). Afreena Nasir is often cited by papers focused on Natural Antidiabetic Agents Studies (4 papers), Diet, Metabolism, and Disease (4 papers) and Andrographolide Research and Applications (1 paper). Afreena Nasir collaborates with scholars based in India and Nigeria. Afreena Nasir's co-authors include Suman Sharma, K. M. Prabhu, P. S. Murthy, Geeta Dev, P. Suryanarayana Murthy, Vivek Kumar Bains and Manju Nehra and has published in prestigious journals such as Journal of Ethnopharmacology, Evidence-based Complementary and Alternative Medicine and Journal of Medicinal Food.

In The Last Decade

Afreena Nasir

7 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Afreena Nasir India 6 400 174 120 98 95 7 552
Abigail Aguilar-Contreras Mexico 7 327 0.8× 269 1.5× 115 1.0× 110 1.1× 121 1.3× 12 622
Uttam Das India 6 306 0.8× 150 0.9× 71 0.6× 80 0.8× 91 1.0× 19 481
B Kameswara Rao India 7 533 1.3× 182 1.0× 142 1.2× 139 1.4× 117 1.2× 8 777
Ajit Kar India 5 330 0.8× 308 1.8× 141 1.2× 67 0.7× 171 1.8× 10 662
Dieudonné Kuate Cameroon 14 224 0.6× 157 0.9× 70 0.6× 86 0.9× 63 0.7× 29 542
L Anila India 6 199 0.5× 170 1.0× 143 1.2× 149 1.5× 139 1.5× 6 547
J. Eliza United States 9 455 1.1× 244 1.4× 117 1.0× 130 1.3× 145 1.5× 9 775
Sharieh Hosseini Iran 12 184 0.5× 131 0.8× 126 1.1× 121 1.2× 103 1.1× 18 683
Y Tanko Nigeria 12 206 0.5× 201 1.2× 112 0.9× 59 0.6× 92 1.0× 86 522
A.N. Nagappa India 5 220 0.6× 140 0.8× 74 0.6× 61 0.6× 99 1.0× 19 407

Countries citing papers authored by Afreena Nasir

Since Specialization
Citations

This map shows the geographic impact of Afreena Nasir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afreena Nasir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afreena Nasir more than expected).

Fields of papers citing papers by Afreena Nasir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afreena Nasir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afreena Nasir. The network helps show where Afreena Nasir may publish in the future.

Co-authorship network of co-authors of Afreena Nasir

This figure shows the co-authorship network connecting the top 25 collaborators of Afreena Nasir. A scholar is included among the top collaborators of Afreena Nasir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afreena Nasir. Afreena Nasir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Nasir, Afreena, et al.. (2020). Lipid peroxidation and antioxidant status in cigarette smokers ischemic heart disease (IHD) patients. International Journal of Advanced Biochemistry Research. 4(2). 17–19. 1 indexed citations
2.
Nasir, Afreena, et al.. (2013). Hepatoprotective Effect of the Aqueous Leaf Extract of Andrographis paniculata Nees Against Carbon Tetrachloride – Induced Hepatotoxicity in Rats. Nigerian Journal of Basic and Applied Sciences. 21(1). 28 indexed citations
3.
Bains, Vivek Kumar, et al.. (2012). Management of pulpal floor perforation and grade II Furcation involvement using mineral trioxide aggregate and platelet rich fibrin: A clinical report. Contemporary Clinical Dentistry. 3(6). 223–223. 29 indexed citations
4.
Sharma, Suman, et al.. (2011). Antihyperlipidemic Effect of Active Principle Isolated from Seed of Eugenia jambolana on Alloxan-Induced Diabetic Rabbits. Journal of Medicinal Food. 14(4). 353–359. 25 indexed citations
5.
Sharma, Suman, et al.. (2010). Ameliorative Effect of Active Principle Isolated from Seeds of Eugenia jambolana on Carbohydrate Metabolism in Experimental Diabetes. Evidence-based Complementary and Alternative Medicine. 2011(1). 789871–789871. 29 indexed citations
6.
Sharma, Suman, Afreena Nasir, K. M. Prabhu, & P. Suryanarayana Murthy. (2006). Antihyperglycemic effect of the fruit-pulp of Eugenia jambolana in experimental diabetes mellitus. Journal of Ethnopharmacology. 104(3). 367–373. 157 indexed citations
7.
Sharma, Suman, Afreena Nasir, K. M. Prabhu, P. S. Murthy, & Geeta Dev. (2003). Hypoglycaemic and hypolipidemic effect of ethanolic extract of seeds of Eugenia jambolana in alloxan-induced diabetic rabbits. Journal of Ethnopharmacology. 85(2-3). 201–206. 283 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026